Drugs / COAGULATION FACTOR IX HUMAN
COAGULATION FACTOR IX HUMAN
also known as
Coagulation factor ix human component of balfaxar · Factor ix human · human coagulation Factor IX · Mononine · Nonafact · Replenine
Protein / enzyme biologic targets F9
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Nonafact | — | 2001-07-03 | europa.eu ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00139828 | May 2003 → Feb 2007 | hemophilia B | Prothya Biosolutions | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COAGULATION FACTOR IX HUMAN | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297986 ↗ |
| Known as | Coagulation factor ix human component of balfaxar | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297986 ↗ |
| Known as | Factor ix human | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297986 ↗ |
| Known as | human coagulation Factor IX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00139828 ↗ |
| Known as | Mononine | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297986 ↗ |
| Known as | Nonafact | “Nonafact” NCT00139828 ↗ |
| Known as | Replenine | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297986 ↗ |
| Modality | Protein / enzyme biologic | “Human Plasma Derived Factor IX Product” NCT00139828 ↗ |
| Target | F9 | “Coagulation factor IX exogenous protein” CHEMBL4297986 ↗ |